Suppr超能文献

普及检测与治疗试验向我们揭示了实现艾滋病流行控制的道路?

What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?

机构信息

Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Brigham and Women's Hospital, Boston, MA, USA.

出版信息

J Int AIDS Soc. 2020 Feb;23(2):e25455. doi: 10.1002/jia2.25455.

Abstract

INTRODUCTION

Achieving HIV epidemic control globally will require new strategies to accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was evaluated in four randomized population-based trials (BCPP/Ya Tsie, HPTN 071/PopART, SEARCH, ANRS 12249/TasP) conducted in sub-Saharan Africa (SSA) during expanded antiretroviral treatment (ART) eligibility by World Health Organization guidelines and the UNAIDS 90-90-90 campaign.

DISCUSSION

These three-year studies were conducted in Botswana, Zambia, Uganda, Kenya and South Africa in settings with baseline HIV prevalence from 4% to 30%. Key observations across studies were: (1) Universal testing (implemented via a variety of home and community-based testing approaches) achieved >90% coverage in all studies. (2) When coupled with robust linkage to HIV care, rapid ART start and patient-centred care, UTT achieved among the highest reported population levels of viral suppression in SSA. Significant gains in population-level viral suppression were made in regions with both low and high baseline population viral load; however, viral suppression gains were not uniform across all sub-populations and were lower among youth. (3) UTT resulted in marked reductions in community HIV incidence when universal testing and robust linkage were present. However, HIV elimination targets were not reached. In BCPP and HPTN 071, annualized HIV incidence was approximately 20% to 30% lower in the intervention (which included universal testing) compared to control arms (no universal testing). In SEARCH (where both arms had universal testing), incidence declined 32% over three years. (4) UTT reduced HIV associated mortality by 23% in the intervention versus control communities in SEARCH, a study in which mortality was comprehensively measured.

CONCLUSIONS

These trials provide strong evidence that UTT inclusive of universal testing increases population-level viral suppression and decreases HIV incidence and mortality faster than the status quo in SSA and should be adapted at a sub-country level as a public health strategy. However, more is needed, including integration of new prevention interventions into UTT, in order to reach UNAIDS HIV elimination targets.

摘要

简介

要在全球范围内控制艾滋病疫情,就需要采取新策略来加快降低艾滋病发病率和死亡率。在世界卫生组织扩大抗逆转录病毒治疗资格标准和联合国艾滋病规划署“90-90-90”运动的指导下,四项在撒哈拉以南非洲(SSA)进行的基于人群的随机对照试验(BCPP/Ya Tsie、HPTN 071/PopART、SEARCH、ANRS 12249/TasP)评估了普遍检测和治疗(UTT)。

讨论

这三项为期三年的研究分别在博茨瓦纳、赞比亚、乌干达、肯尼亚和南非开展,基线 HIV 流行率在 4%至 30%之间。研究中的主要观察结果包括:(1)普遍检测(通过各种家庭和社区检测方法实施)在所有研究中均达到了>90%的覆盖率。(2)当与强有力的 HIV 护理衔接、快速开始 ART 和以患者为中心的护理相结合时,UTT 在 SSA 实现了报告的最高人群水平的病毒抑制率。在基线人群病毒载量较低和较高的地区,均取得了人群水平病毒抑制率的显著提高;然而,并非所有亚人群都取得了一致的病毒抑制率提高,年轻人的提高幅度较低。(3)当普遍检测和强有力的衔接存在时,UTT 导致社区 HIV 发病率显著降低。然而,艾滋病毒消除目标并未实现。在 BCPP 和 HPTN 071 中,与对照组(无普遍检测)相比,干预组(包括普遍检测)的年化 HIV 发病率降低了约 20%至 30%。在 SEARCH 中,(两组均进行了普遍检测),三年内发病率下降了 32%。(4)在 SEARCH 中,与对照组社区相比,干预组的 HIV 相关死亡率降低了 23%,该研究全面测量了死亡率。

结论

这些试验提供了强有力的证据,表明包括普遍检测在内的 UTT 可提高人群水平的病毒抑制率,并比 SSA 的现状更快地降低 HIV 发病率和死亡率,应作为一项公共卫生策略在国家以下层面进行调整。然而,还需要更多措施,包括将新的预防干预措施纳入 UTT,以实现联合国艾滋病规划署的艾滋病毒消除目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/693b/7038879/62509ac18235/JIA2-23-e25455-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验